SULPHONAMIDE DERIVATIVES

The invention relates to sulphonamide derivatives of formula (I), where RC is selected from a group consisting of dialkylamino, NO2, CN, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkanoyl, oxazol-2-yl, oxazolylaminocarbonyl, aryl, aroyl, aryl-CH(OH)-, arylaminocarbonyl, furanyl, w...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSON, MARK, KAEPYLAE, JARMO, MARJAMAEKI, ANNE, NISSINEN, LIISA, OJALA, MARIKA, PIHLAVISTO, MARJO, HEINO, JYRKI, NYROENEN, TOMMI, PENTIKAEINEN, OLLI
Format Patent
LanguageEnglish
French
German
Published 28.05.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to sulphonamide derivatives of formula (I), where RC is selected from a group consisting of dialkylamino, NO2, CN, aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl, alkanoyl, oxazol-2-yl, oxazolylaminocarbonyl, aryl, aroyl, aryl-CH(OH)-, arylaminocarbonyl, furanyl, where the aryl, aroyl and furanyl moieties may be substituted, guanidinyl-(CH2)z-N(R')-, Het-(CH2)z-N(R')-, Het-CO-N(R')-, Het-CH(OH)- and Het-CO-, where Het is an optionally substituted 4-6-membered heterocyclic ring containing one or more heteroatoms sleeted from N, S and O, R' is hydrogen or alkyl, and z is an integer 1 to 5; RA is a group of formula (A), (B), (C) or (D) as defined in the claims; and RB is hydrogen, alkyl, alkanoyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, aminoalkyl, mono- or dialkylaminoalkyl or Het-alkyl, where Het is as defined above. The invention also relates to the use of derivatives of formula (I) as inhibitors for collagen receptor integrins and a process for preparing sulphonamides of formula (II).
Bibliography:Application Number: EP20060820086